PD-1, a receptor for B7-4, and uses therefor
View Patent ↗The invention identifies PD-1 as a receptor for B7-4. B7-4 can inhibit immune cell activation upon binding to an inhibitory receptor on an immune cell. Accordingly, the invention provides agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response.
1. A method for upmodulating an immune response comprising administering an agent that downmodulates signaling via PD-1, wherein the agent comprises an antibody that binds a B7-4 polypeptide comprising the amino acid sequence shown in SEQ ID NO:4, to thereby upmodulate the immune response.
2. The method of claim 1 , wherein the immune response is upmodulated in a cell selected from the group consisting of: a T cell, a B cell, and a myeloid cell.
3. The method of claim 1 , wherein the step of administering occurs in vivo.
4. The method of claim 1 , wherein the step of administering occurs in vitro.
5. The method of claim 1 , wherein the step of administering comprises contacting an antigen presenting cell selected from the group consisting of a monocyte, a dendritic cell, a keratinocyte and a B cell.